The Genetics of Dystonias

Advances in Genetics

Volumn 79, Issue , 2012, Pages 35-85

  LeDoux, Mark S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

CIZ1; G1 S cell cycle checkpoint; Paroxysmal kinesigenic dyskinesia; THAP1; TorsinA

Indexed keywords

EID: 84866393186     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-394395-8.00002-5     Document Type: Chapter

References (202)

1. Alazami A.M., Al-Saif A., Al-Semari A., Bohlega S., Zlitni S., Alzahrani F., Bavi P., Kaya N., Colak D., Khalak H., et al. Mutations in C2orf37, encoding a nucleolar protein, cause hypogonadism, alopecia, diabetes mellitus, mental retardation, and extrapyramidal syndrome. Am. J. Hum. Genet. 2008, 83:684-691.
2. Aquino D., Bizzi A., Grisoli M., Garavaglia B., Bruzzone M.G., Nardocci N., Savoiardo M., Chiapparini L. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009, 252:165-172.
3. Arpa J., Cuesta A., Cruz-Martinez A., Santiago S., Sarria J., Palau F. Clinical features and genetic analysis of a Spanish family with spinocerebellar ataxia 6. Acta Neurol. Scand. 1999, 99:43-47.
4. Asmus F., Salih F., Hjermind L.E., Ostergaard K., Munz M., Kuhn A.A., Dupont E., Kupsch A., Gasser T. Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene. Ann. Neurol. 2005, 58:792-797.
5. Auburger G., Ratzlaff T., Lunkes A., Nelles H.W., Leube B., Binkofski F., Kugel H., Heindel W., Seitz R., Benecke R., et al. A gene for autosomal dominant paroxysmal choreoathetosis/spasticity (CSE) maps to the vicinity of a potassium channel gene cluster on chromosome 1p, probably within 2 cM between D1S443 and D1S197. Genomics 1996, 31:90-94.
6. Augood S.J., Keller-McGandy C.E., Siriani A., Hewett J., Ramesh V., Sapp E., DiFiglia M., Breakefield X.O., Standaert D.G. Distribution and ultrastructural localization of torsinA immunoreactivity in the human brain. Brain Res. 2003, 986:12-21.
7. Baker M., Litvan I., Houlden H., Adamson J., Dickson D., Perez-Tur J., Hardy J., Lynch T., Bigio E., Hutton M. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 1999, 8:711-715.
8. Barclay C.L., Lang A.E. Dystonia in progressive supranuclear palsy. J. Neurol. Neurosurg. Psychiatry 1997, 62:352-356.
9. Basham S.E., Rose L.S. The Caenorhabditis elegans polarity gene ooc-5 encodes a Torsin-related protein of the AAA ATPase superfamily. Development 2001, 128:4645-4656.
10. Benecke R., Strumper P., Weiss H. Electron transfer complex I defect in idiopathic dystonia. Ann. Neurol. 1992, 32:683-686.
11. Bennett L.B., Roach E.S., Bowcock A.M. A locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16. Neurology 2000, 54:125-130.
12. Bentivoglio A.R., Ialongo T., Contarino M.F., Valente E.M., Albanese A. Phenotypic characterization of DYT13 primary torsion dystonia. Mov. Disord. 2004, 19:200-206.
13. Bhatia K.P. Paroxysmal dyskinesias. Mov. Disord. 2011, 26:1157-1165.
14. Bonafé L., Thöny B., Penzien J.M., Czarnecki B., Blau N. Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am. J. Hum. Genet. 2001, 69:269-277.
15. Brashear A., Dobyns W.B., de Carvalho Aguiar P., Borg M., Frijns C.J., Gollamudi S., Green A., Guimaraes J., Haake B.C., Klein C., et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain 2007, 130:828-835.
16. Braun N., Zhu Y., Krieglstein J., Culmsee C., Zimmermann H. Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J. Neurosci. 1998, 18:4891-4900.
17. Bressman S.B., Raymond D., Fuchs T., Heiman G.A., Ozelius L.J., Saunders-Pullman R. Mutations in THAP1 (DYT6) in early-onset dystonia: a genetic screening study. Lancet Neurol. 2009, 8:441-446.
18. Bressman S.B., Sabatti C., Raymond D., de Leon D., Klein C., Kramer P.L., Brin M.F., Fahn S., Breakefield X., Ozelius L.J., et al. The DYT1 phenotype and guidelines for diagnostic testing. Neurology 2000, 54:1746-1752.
19. Bruno M.K., Lee H.Y., Auburger G.W., Friedman A., Nielsen J.E., Lang A.E., Bertini E., Van Bogaert P., Averyanov Y., Hallett M., et al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 2007, 68:1782-1789.
20. Calakos N., Patel V.D., Gottron M., Wang G., Tran-Viet K.N., Brewington D., Beyer J.L., Steffens D.C., Krishnan R.R., Zuchner S. Functional evidence implicating a novel TOR1A mutation in idiopathic, late-onset focal dystonia. J. Med. Genetic. 2010, 47:646-650.
21. Caldwell G.A., Cao S., Sexton E.G., Gelwix C.C., Bevel J.P., Caldwell K.A. Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins. Hum. Mol. Genet. 2003, 12:307-319.
22. Callan A.C., Bunning S., Jones O.T., High S., Swanton E. Biosynthesis of the dystonia-associated AAA+ ATPase torsinA at the endoplasmic reticulum. Biochem. J. 2007, 401:607-612.
23. Camargos S., Scholz S., Simon-Sanchez J., Paisan-Ruiz C., Lewis P., Hernandez D., Ding J., Gibbs J.R., Cookson M.R., Bras J., et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol. 2008, 7:207-215.
24. Cao S., Gelwix C.C., Caldwell K.A., Caldwell G.A. Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 2005, 25:3801-3812.
25. Chen W.J., Lin Y., Xiong Z.Q., Wei W., Ni W., Tan G.H., Guo S.L., He J., Chen Y.F., Zhang Q.J., et al. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. Nat. Genet. 2011, 43:1252-1255.
26. Cheng F.B., Ozelius L.J., Wan X.H., Feng J.C., Ma L.Y., Yang Y.M., Wang L. THAP1/DYT6 sequence variants in non-DYT1 early-onset primary dystonia in China and their effects on RNA expression. J. Neurol. 2011, 259:342-347.
27. Chouery E., Kfoury J., Delague V., Jalkh N., Bejjani P., Serre J.L., Megarbane A. A novel locus for autosomal recessive primary torsion dystonia (DYT17) maps to 20p11.22-q13.12. Neurogenetics 2008, 9:287-293.
28. Choumert A., Poisson A., Honnorat J., Le Ber I., Camuzat A., Broussolle E., Thobois S. G303V tau mutation presenting with progressive supranuclear palsy-like features. Mov. Disord. 2011, 10.1002/mds.24060.
29. Clouaire T., Roussigne M., Ecochard V., Mathe C., Amalric F., Girard J.P. The THAP domain of THAP1 is a large C2CH module with zinc-dependent sequence-specific DNA-binding activity. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:6907-6912.
30. de Carvalho Aguiar P., Sweadner K.J., Penniston J.T., Zaremba J., Liu L., Caton M., Linazasoro G., Borg M., Tijssen M.A., Bressman S.B., et al. Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004, 43:169-175.
31. Defazio G., Abbruzzese G., Aniello M.S., Bloise M., Crisci C., Eleopra R., Fabbrini G., Girlanda P., Liguori R., Macerollo A., et al. Environmental risk factors and clinical phenotype in familial and sporadic primary blepharospasm. Neurology 2011, 77:631-637.
32. Djarmati A., Schneider S.A., Lohmann K., Winkler S., Pawlack H., Hagenah J., Bruggemann N., Zittel S., Fuchs T., Rakovic A., et al. Mutations in THAP1 (DYT6) and generalised dystonia with prominent spasmodic dysphonia: a genetic screening study. Lancet Neurol. 2009, 8:447-452.
33. Dudesek A., Roschinger W., Muntau A.C., Seidel J., Leupold D., Thöny B., Blau N. Molecular analysis and long-term follow-up of patients with different forms of 6-pyruvoyl-tetrahydropterin synthase deficiency. Eur. J. Pediatr. 2001, 160:267-276.
34. Edwards M., Wood N., Bhatia K. Unusual phenotypes in DYT1 dystonia: a report of five cases and a review of the literature. Mov. Disord. 2003, 18:706-711.
35. Einholm A.P., Toustrup-Jensen M.S., Holm R., Andersen J.P., Vilsen B. The rapid-onset dystonia parkinsonism mutation D923N of the Na+, K+-ATPase alpha3 isoform disrupts Na+ interaction at the third Na+ site. J. Biol. Chem. 2010, 285:26245-26254.
36. Esapa C.T., Waite A., Locke M., Benson M.A., Kraus M., McIlhinney R.A., Sillitoe R.V., Beesley P.W., Blake D.J. SGCE missense mutations that cause myoclonus-dystonia syndrome impair epsilon-sarcoglycan trafficking to the plasma membrane: modulation by ubiquitination and torsinA. Hum. Mol. Genet. 2007, 16:327-342.
37. Evidente V.G., Advincula J., Esteban R., Pasco P., Alfon J.A., Natividad F.F., Cuanang J., Luis A.S., Gwinn-Hardy K., Hardy J., et al. Phenomenology of " Lubag" or X-linked dystonia-parkinsonism. Mov. Disord. 2002, 17:1271-1277.
38. Fahn S. Systemic therapy of dystonia. Can. J. Neurol. Sci. 1987, 14:528-532.
39. Fahn S. Concept and classification of dystonia. Adv. Neurol. 1988, 50:1-8.
40. Fahn S. Classification of movement disorders. Mov. Disord. 2011, 26:947-957.
41. Fahn S., Bressman S.B., Marsden C.D. Classification of dystonia. Adv. Neurol. 1998, 78:1-10.
42. Ferrari-Toninelli G., Paccioretti S., Francisconi S., Uberti D., Memo M. TorsinA negatively controls neurite outgrowth of SH-SY5Y human neuronal cell line. Brain Res. 2004, 1012:75-81.
43. Finsterer J. Leigh and Leigh-like syndrome in children and adults. Pediatr. Neurol. 2008, 39:223-235.
44. Frédéric M., Lucarz E., Monino C., Saquet C., Thorel D., Claustres M., Tuffery-Giraud S., Collod-Beroud G. First determination of the incidence of the unique TOR1A gene mutation, c.907delGAG, in a Mediterranean population. Mov. Disord. 2007, 22:884-888.
45. Frédéric M.Y., Clot F., Blanchard A., Dhaenens C.M., Lesca G., Cif L., Durr A., Vidailhet M., Sablonniere B., Calender A., et al. The p.Asp216His TOR1A allele effect is not found in the French population. Mov. Disord. 2009, 24:919-921.
46. Fuchs T., Gavarini S., Saunders-Pullman R., Raymond D., Ehrlich M.E., Bressman S.B., Ozelius L.J. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat. Genet. 2009, 41:286-288.
47. Gajos A., Piaskowski S., Slawek J., Ochudlo S., Opala G., Lobinska A., Honczarenko K., Budrewicz S., Koszewicz M., Pelszynska B., et al. Phenotype of the DYT1 mutation in the TOR1A gene in a Polish population of patients with dystonia. A preliminary report. Neurol. Neurochir. Pol. 2007, 41:487-494.
48. Gambarin M., Valente E.M., Liberini P., Barrano G., Bonizzato A., Padovani A., Moretto G., Fiorio M., Dallapiccola B., Smania N., et al. Atypical phenotypes and clinical variability in a large Italian family with DYT1-primary torsion dystonia. Mov. Disord. 2006, 21:1782-1784.
49. Gasser T., Windgassen K., Bereznai B., Kabus C., Ludolph A.C. Phenotypic expression of the DYT1 mutation: a family with writer's cramp of juvenile onset. Ann. Neurol. 1998, 44:126-128.
50. Geschwind D.H., Loginov M., Stern J.M. Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am. J. Hum. Genet. 1999, 65:764-772.
51. Getty A.L., Pearce D.A. Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function. Cell. Mol. Life Sci. 2011, 68:453-474.
52. Ghezzi D., Viscomi C., Ferlini A., Gualandi F., Mereghetti P., DeGrandis D., Zeviani M. Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence. Hum. Mol. Genet. 2009, 18:1058-1064.
53. Gilbert D.L., Leslie E.J., Keddache M., Leslie N.D. A novel hereditary spastic paraplegia with dystonia linked to chromosome 2q24-2q31. Mov. Disord. 2009, 24:364-370.
54. Gimenez-Roldan S., Delgado G., Marin M., Villanueva J.A., Mateo D. Hereditary torsion dystonia in gypsies. Adv. Neurol. 1988, 50:73-81.
55. Goetz C.G., Chmura T.A., Lanska D.J. History of dystonia: part 4 of the MDS-sponsored history of movement disorders exhibit, Barcelona, June, 2000. Mov. Disord. 2001, 16:339-345.
56. Goodchild R.E., Dauer W.T. Mislocalization to the nuclear envelope: an effect of the dystonia-causing torsinA mutation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:847-852.
57. Goodchild R.E., Dauer W.T. The AAA+ protein torsinA interacts with a conserved domain present in LAP1 and a novel ER protein. J. Cell Biol. 2005, 168:855-862.
58. Goodchild R.E., Kim C.E., Dauer W.T. Loss of the dystonia-associated protein torsinA selectively disrupts the neuronal nuclear envelope. Neuron 2005, 48:923-932.
59. Goto S., Lee L.V., Munoz E.L., Tooyama I., Tamiya G., Makino S., Ando S., Dantes M.B., Yamada K., Matsumoto S., et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann. Neurol. 2005, 58:7-17.
60. Groen J.L., Ritz K., Contarino M.F., van de Warrenburg B.P., Aramideh M., Foncke E.M., van Hilten J.J., Schuurman P.R., Speelman J.D., Koelman J.H., et al. DYT6 dystonia: mutation screening, phenotype, and response to deep brain stimulation. Mov. Disord. 2010, 25:2420-2427.
61. Grotzsch H., Pizzolato G.P., Ghika J., Schorderet D., Vingerhoets F.J., Landis T., Burkhard P.R. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology 2002, 58:1839-1842.
62. Grundmann K., Laubis-Herrmann U., Bauer I., Dressler D., Vollmer-Haase J., Bauer P., Stuhrmann M., Schulte T., Schols L., Topka H., et al. Frequency and phenotypic variability of the GAG deletion of the DYT1 gene in an unselected group of patients with dystonia. Arch. Neurol. 2003, 60:1266-1270.
63. Grunewald A., Djarmati A., Lohmann-Hedrich K., Farrell K., Zeller J.A., Allert N., Papengut F., Petersen B., Fung V., Sue C.M., et al. Myoclonus-dystonia: significance of large SGCE deletions. Hum. Mutat. 2008, 29:331-332.
64. Hagenah J., Reetz K., Zuhlke C., Rolfs A., Binkofski F., Klein C. Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology 2007, 68:2157.
65. Hagenah J.M., Zuhlke C., Hellenbroich Y., Heide W., Klein C. Focal dystonia as a presenting sign of spinocerebellar ataxia 17. Mov. Disord. 2004, 19:217-220.
66. Hedera P., Phibbs F.T., Fang J.Y., Cooper M.K., Charles P.D., Davis T.L. Clustering of dystonia in some pedigrees with autosomal dominant essential tremor suggests the existence of a distinct subtype of essential tremor. BMC Neurol. 2010, 10:66.
67. Hewett J.W., Zeng J., Niland B.P., Bragg D.C., Breakefield X.O. Dystonia-causing mutant torsinA inhibits cell adhesion and neurite extension through interference with cytoskeletal dynamics. Neurobiol. Dis. 2006, 22:98-111.
68. Holmgren G., Ozelius L., Forsgren L., Almay B.G., Holmberg M., Kramer P., Fahn S., Breakefield X.O. Adult onset idiopathic torsion dystonia is excluded from the DYT 1 region (9q34) in a Swedish family. J. Neurol. Neurosurg. Psychiatry 1995, 59:178-181.
69. Horvath G.A., Stockler-Ipsiroglu S.G., Salvarinova-Zivkovic R., Lillquist Y.P., Connolly M., Hyland K., Blau N., Rupar T., Waters P.J. Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms. Mol. Genet. Metab. 2008, 94:127-131.
70. Hou J.G., Jankovic J. Movement disorders in Friedreich's ataxia. J. Neurol. Sci. 2003, 206:59-64.
71. Houlden H., Baker M., Morris H.R., MacDonald N., Pickering-Brown S., Adamson J., Lees A.J., Rossor M.N., Quinn N.P., Kertesz A., et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 2001, 56:1702-1706.
72. Houlden H., Schneider S.A., Paudel R., Melchers A., Schwingenschuh P., Edwards M., Hardy J., Bhatia K.P. THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. Neurology 2010, 74:846-850.
73. Hutchins J.B., Casagrande V.A. Vimentin: changes in distribution during brain development. Glia 1989, 2:55-66.
74. Ichinose H., Ohye T., Takahashi E., Seki N., Hori T., Segawa M., Nomura Y., Endo K., Tanaka H., Tsuji S., et al. Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nat. Genet. 1994, 8:236-242.
75. Jinnah H.A., Ceballos-Picot I., Torres R.J., Visser J.E., Schretlen D.J., Verdu A., Larovere L.E., Chen C.J., Cossu A., Wu C.H., et al. Attenuated variants of Lesch-Nyhan disease. Brain 2010, 133:671-689.
76. Kabakci K., Hedrich K., Leung J.C., Mitterer M., Vieregge P., Lencer R., Hagenah J., Garrels J., Witt K., Klostermann F., et al. Mutations in DYT1: extension of the phenotypic and mutational spectrum. Neurology 2004, 62:395-400.
77. Kabakci K., Isbruch K., Schilling K., Hedrich K., de Carvalho Aguiar P., Ozelius L.J., Kramer P.L., Schwarz M.H., Klein C. Genetic heterogeneity in rapid onset dystonia-parkinsonism: description of a new family. J. Neurol. Neurosurg. Psychiatry 2005, 76:860-862.
78. Kamm C., Boston H., Hewett J., Wilbur J., Corey D.P., Hanson P.I., Ramesh V., Breakefield X.O. The early onset dystonia protein torsinA interacts with kinesin light chain 1. J. Biol. Chem. 2004, 279:19882-19892.
79. Khan N.L., Graham E., Critchley P., Schrag A.E., Wood N.W., Lees A.J., Bhatia K.P., Quinn N. Parkin disease: a phenotypic study of a large case series. Brain 2003, 126:1279-1292.
80. Khan N.L., Wood N.W., Bhatia K.P. Autosomal recessive, DYT2-like primary torsion dystonia: a new family. Neurology 2003, 61:1801-1803.
81. Kim H.T., Edwards M.J., Tyson J., Quinn N.P., Bitner-Glindzicz M., Bhatia K.P. Blepharospasm and limb dystonia caused by Mohr-Tranebjaerg syndrome with a novel splice-site mutation in the deafness/dystonia peptide gene. Mov. Disord. 2007, 22:1328-1331.
82. Kindy M.S., Bhat A.N., Bhat N.R. Transient ischemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus. Mol. Brain Res. 1992, 13:199-206.
83. Klein C., Liu L., Doheny D., Kock N., Muller B., de Carvalho Aguiar P., Leung J., de Leon D., Bressman S.B., Silverman J., et al. Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutations. Ann. Neurol. 2002, 52:675-679.
84. Konakova M., Huynh D.P., Yong W., Pulst S.M. Cellular distribution of torsin A and torsin B in normal human brain. Arch. Neurol. 2001, 58:921-927.
85. Konakova M., Pulst S.M. Immunocytochemical characterization of torsin proteins in mouse brain. Brain Res. 2001, 922:1-8.
86. Kuczmarski R.J., Ogden C.L., Grummer-Strawn L.M., Flegal K.M., Guo S.S., Wei R., Mei Z., Curtin L.R., Roche A.F., Johnson C.L. CDC growth charts: United States. Adv. Data 2000, 314:1-27.
87. Kuner R., Teismann P., Trutzel A., Naim J., Richter A., Schmidt N., Bach A., Ferger B., Schneider A. TorsinA, the gene linked to early-onset dystonia, is upregulated by the dopaminergic toxin MPTP in mice. Neurosci. Lett. 2004, 355:126-130.
88. Kuner R., Teismann P., Trutzel A., Naim J., Richter A., Schmidt N., von Ahsen O., Bach A., Ferger B., Schneider A. TorsinA protects against oxidative stress in COS-1 and PC12 cells. Neurosci. Lett. 2003, 350:153-156.
89. Larnaout A., Belal S., Miladi N., Kaabachi N., Mebazza A., Dhondt J.L., Hentati F. Juvenile form of dihydropteridine reductase deficiency in 2 Tunisian patients. Neuropediatrics 1998, 29:322-323.
90. Le Ber I., Clot F., Vercueil L., Camuzat A., Viemont M., Benamar N., De Liege P., Ouvrard-Hernandez A.M., Pollak P., Stevanin G., et al. Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology 2006, 67:1769-1773.
91. LeDoux M.S. Meige syndrome: what's in a name?. Parkinsonism Relat. Disord. 2009, 15:483-489.
92. LeDoux M.S. Dystonia: phenomenology. Parkinsonism Relat Disord. 2012, 18(Supp 1):S162-164.
93. LeDoux M.S., Xiao J., Rudzińska M., Bastian R.W., Wszolek Z.K., Van Gerpen J.A., Puschmann A., Momčilović D., Vemula S., Zhao Y. Genotype-phenotype correlations in THAP1 dystonia: molecular foundations and description of new cases. Parkinsonism Relat. Disord. 2012, 18:414-425.
94. Lee H.Y., Xu Y., Huang Y., Ahn A.H., Auburger G.W., Pandolfo M., Kwiecinski H., Grimes D.A., Lang A.E., Nielsen J.E., et al. The gene for paroxysmal non-kinesigenic dyskinesia encodes an enzyme in a stress response pathway. Hum. Mol. Genet. 2004, 13:3161-3170.
95. Lee W.L., Tay A., Ong H.T., Goh L.M., Monaco A.P., Szepetowski P. Association of infantile convulsions with paroxysmal dyskinesias (ICCA syndrome): confirmation of linkage to human chromosome 16p12-q12 in a Chinese family. Hum. Genet. 1998, 103:608-612.
96. Leube B., Hendgen T., Kessler K.R., Knapp M., Benecke R., Auburger G. Sporadic focal dystonia in northwest Germany: molecular basis on chromosome 18p. Ann. Neurol. 1997, 42:111-114.
97. Leube B., Kessler K.R., Ferbert A., Ebke M., Schwendemann G., Erbguth F., Benecke R., Auburger G. Phenotypic variability of the DYT1 mutation in German dystonia patients. Acta Neurol. Scand. 1999, 99:248-251.
98. Leube B., Rudnicki D., Ratzlaff T., Kessler K.R., Benecke R., Auburger G. Idiopathic torsion dystonia: assignment of a gene to chromosome 18p in a German family with adult onset, autosomal dominant inheritance and purely focal distribution. Hum. Mol. Genet. 1996, 5:1673-1677.
99. Leung J.C., Klein C., Friedman J., Vieregge P., Jacobs H., Doheny D., Kamm C., DeLeon D., Pramstaller P.P., Penney J.B., et al. Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 2001, 3:133-143.
100. Li J., Zhu X., Wang X., Sun W., Feng B., Du T., Sun B., Niu F., Wei H., Wu X., et al. Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. J. Med. Genet. 2012, 49:76-78.
101. Liu Q., Qi Z., Wan X.H., Li J.Y., Shi L., Lu Q., Zhou X.Q., Qiao L., Wu L.W., Liu X.Q., et al. Mutations in PRRT2 result in paroxysmal dyskinesias with marked variability in clinical expression. J. Med. Genet. 2012, 49:79-82.
102. Lohmann E., Koroglu C., Hanagasi H.A., Dursun B., Tasan E., Tolun A. A homozygous frameshift mutation of sepiapterin reductase gene causing parkinsonism with onset in childhood. Parkinsonism Relat. Disord. 2012, 18:191-193.
103. Lohmann K., Uflacker N., Erogullari A., Lohnau T., Winkler S., Dendorfer A., Schneider S.A., Osmanovic A., Svetel M., Ferbert A., et al. Identification and functional analysis of novel THAP1 mutations. Eur. J. Hum. Genet. 2012, 20:171-175.
104. Lüdecke B., Dworniczak B., Bartholomé K. A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome. Hum. Genet. 1995, 95:123-125.
105. Makino S., Kaji R., Ando S., Tomizawa M., Yasuno K., Goto S., Matsumoto S., Tabuena M.D., Maranon E., Dantes M., et al. Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am. J. Hum. Genet. 2007, 80:393-406.
106. Marras C., Van den Eeden S.K., Fross R.D., Benedict-Albers K.S., Klingman J., Leimpeter A.D., Nelson L.M., Risch N., Karter A.J., Bernstein A.L., et al. Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology 2007, 69:676-680.
107. McLean P.J., Kawamata H., Shariff S., Hewett J., Sharma N., Ueda K., Breakefield X.O., Hyman B.T. TorsinA and heat shock proteins act as molecular chaperones: suppression of alpha-synuclein aggregation. J. Neurochem. 2002, 83:846-854.
108. McNeill A., Birchall D., Hayflick S.J., Gregory A., Schenk J.F., Zimmerman E.A., Shang H., Miyajima H., Chinnery P.F. T2* and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation. Neurology 2008, 70:1614-1619.
109. Moretti P., Hedera P., Wald J., Fink J. Autosomal recessive primary generalized dystonia in two siblings from a consanguineous family. Mov. Disord. 2005, 20:245-247.
110. Naismith T.V., Heuser J.E., Breakefield X.O., Hanson P.I. TorsinA in the nuclear envelope. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7612-7617.
111. Nery F.C., Zeng J., Niland B.P., Hewett J., Farley J., Irimia D., Li Y., Wiche G., Sonnenberg A., Breakefield X.O. TorsinA binds the KASH domain of nesprins and participates in linkage between nuclear envelope and cytoskeleton. J. Cell Sci. 2008, 121:3476-3486.
112. Neuwald A.F., Aravind L., Spouge J.L., Koonin E.V. AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 1999, 9:27-43.
113. Nolte D., Niemann S., Müller U. Specific sequence changes in multiple transcript system DYT3 are associated with X-linked dystonia parkinsonism. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10347-10352.
114. Norgren N., Mattson E., Forsgren L., Holmberg M. A high-penetrance form of late-onset torsion dystonia maps to a novel locus (DYT21) on chromosome 2q14.3-q21.3. Neurogenetics 2011, 12:137-143.
115. Ogura T., Wilkinson A.J. AAA+ superfamily ATPases: common structure-diverse function. Genes Cells 2001, 6:575-597.
116. Oliveira J.R., Spiteri E., Sobrido M.J., Hopfer S., Klepper J., Voit T., Gilbert J., Wszolek Z.K., Calne D.B., Stoessl A.J., et al. Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology 2004, 63:2165-2167.
117. Opal P., Tintner R., Jankovic J., Leung J., Breakefield X.O., Friedman J., Ozelius L. Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov. Disord. 2002, 17:339-345.
118. Opladen T., Hoffmann G., Horster F., Hinz A.B., Neidhardt K., Klein C., Wolf N. Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia. Mov. Disord. 2011, 26:157-161.
119. O'Riordan S., Cockburn D., Barton D., Lynch T., Hutchinson M. Primary torsion dystonia due to the Tor1A GAG deletion in an Irish family. Ir. J. Med. Sci. 2002, 171:31-32.
120. Ozelius L.J., Hewett J.W., Page C.E., Bressman S.B., Kramer P.L., Shalish C., de Leon D., Brin M.F., Raymond D., Corey D.P., et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 1997, 17:40-48.
121. Ozelius L.J., Page C.E., Klein C., Hewett J.W., Mineta M., Leung J., Shalish C., Bressman S.B., de Leon D., Brin M.F., et al. The TOR1A (DYT1) gene family and its role in early onset torsion dystonia. Genomics 1999, 62:377-384.
122. Parker N. Hereditary whispering dysphonia. J. Neurol. Neurosurg. Psychiatry 1985, 48:218-224.
123. Perlman S.L. Spinocerebellar degenerations. Handb. Clin. Neurol. 2011, 100:113-140.
124. Peters G.A., Seachrist D.D., Keri R.A., Sen G.C. The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:10696-10701.
125. Poorkaj P., Muma N.A., Zhukareva V., Cochran E.J., Shannon K.M., Hurtig H., Koller W.C., Bird T.D., Trojanowski J.Q., Lee V.M., et al. An R5L tau mutation in a subject with a progressive supranuclear palsy phenotype. Ann. Neurol. 2002, 52:511-516.
126. Puschmann A., Xiao J., Bastian R.W., Searcy J.A., LeDoux M.S., Wszolek Z.K. An African-American family with dystonia. Parkinsonism Relat. Disord. 2011, 17:547-550.
127. Rainier S., Thomas D., Tokarz D., Ming L., Bui M., Plein E., Zhao X., Lemons R., Albin R., Delaney C., et al. Myofibrillogenesis regulator 1 gene mutations cause paroxysmal dystonic choreoathetosis. Arch. Neurol. 2004, 61:1025-1029.
128. Reich S.G., Grill S.E. Corticobasal degeneration. Curr. Treat. Options Neurol. 2009, 11:179-185.
129. Risch N., de Leon D., Ozelius L., Kramer P., Almasy L., Singer B., Fahn S., Breakefield X., Bressman S. Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat. Genet. 1995, 9:152-159.
130. Risch N.J., Bressman S.B., Senthil G., Ozelius L.J. Intragenic Cis and Trans modification of genetic susceptibility in DYT1 torsion dystonia. Am. J. Hum. Genet. 2007, 80:1188-1193.
131. Ritz K., van Schaik B.D., Jakobs M.E., van Kampen A.H., Aronica E., Tijssen M.A., Baas F. SGCE isoform characterization and expression in human brain: implications for myoclonus-dystonia pathogenesis?. Eur. J. Hum. Genet. 2011, 19:438-444.
132. + -ATPase, associated with familial rapid-onset dystonia parkinsonism, interfere with Na+ interaction by distinct mechanisms. J. Biol. Chem. 2006, 281:18539-18548.
133. Roussigne M., Cayrol C., Clouaire T., Amalric F., Girard J.P. THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies. Oncogene 2003, 22:2432-2442.
134. Sako W., Morigaki R., Kaji R., Tooyama I., Okita S., Kitazato K., Nagahiro S., Graybiel A.M., Goto S. Identification and localization of a neuron-specific isoform of TAF1 in rat brain: implications for neuropathology of DYT3 dystonia. Neuroscience 2011, 189:100-107.
135. Sancho-Tello M., Valles S., Montoliu C., Renau-Piqueras J., Guerri C. Developmental pattern of GFAP and vimentin gene expression in rat brain and in radial glial cultures. Glia 1995, 15:157-166.
136. Santangelo G. Contributo clinico alla conoscenza delle forme familiari della dysbasia lordotica progressiva (spasmo di torsione). Psychiat. Neuropat. 1934, 62:52-77.
137. Schapira A.H., Warner T., Gash M.T., Cleeter M.W., Marinho C.F., Cooper J.M. Complex I function in familial and sporadic dystonia. Ann. Neurol. 1997, 41:556-559.
138. Schneider S.A., Bhatia K.P. Dystonia in the Woodhouse Sakati syndrome: a new family and literature review. Mov. Disord. 2008, 23:592-596.
139. Schneider S.A., Bhatia K.P. Rare causes of dystonia parkinsonism. Curr. Neurol. Neurosci. Rep. 2010, 10:431-439.
140. Schneider S.A., Bhatia K.P. Secondary dystonia-clinical clues and syndromic associations. Eur. J. Neurol. 2010, 17(Suppl. 1):52-57.
141. Schneider S.A., Paisan-Ruiz C., Garcia-Gorostiaga I., Quinn N.P., Weber Y.G., Lerche H., Hardy J., Bhatia K.P. GLUT1 gene mutations cause sporadic paroxysmal exercise-induced dyskinesias. Mov. Disord. 2009, 24:1684-1688.
142. Schneider S.A., Ramirez A., Shafiee K., Kaiser F.J., Erogullari A., Bruggemann N., Winkler S., Bahman I., Osmanovic A., Shafa M.A., et al. Homozygous THAP1 mutations as cause of early-onset generalized dystonia. Mov. Disord. 2011, 26:858-861.
143. Segawa M., Hosaka A., Miyagawa F., Nomura Y., Imai H. Hereditary progressive dystonia with marked diurnal fluctuation. Adv. Neurol. 1976, 14:215-233.
144. Seibler P., Djarmati A., Langpap B., Hagenah J., Schmidt A., Bruggemann N., Siebner H., Jabusch H.C., Altenmuller E., Munchau A., et al. A heterozygous frameshift mutation in PRKRA (DYT16) associated with generalised dystonia in a German patient. Lancet Neurol. 2008, 7:380-381.
145. Sengel C., Gavarini S., Sharma N., Ozelius L.J., Bragg D.C. Dimerization of the DYT6 dystonia protein, THAP1, requires residues within the coiled-coil domain. J. Neurochem. 2011, 118:1087-1100.
146. Sethi K.D., Jankovic J. Dystonia in spinocerebellar ataxia type 6. Mov. Disord. 2002, 17:150-153.
147. Shamim E.A., Chu J., Scheider L.H., Savitt J., Jinnah H.A., Hallett M. Extreme task specificity in writer's cramp. Mov. Disord. 2011, 26:2107-2109.
148. Shan Y., Cortopassi G. HSC20 interacts with frataxin and is involved in iron-sulfur cluster biogenesis and iron homeostasis. Hum. Mol. Genet. 2011, [Epub ahead of print] PubMed PMID: 22171070.
149. Sharma N., Armata I.A., Multhaupt-Buell T.J., Ozelius L.J., Xin W., Sims K.B. Mutation in 5' upstream region of GCHI gene causes familial dopa-responsive dystonia. Mov. Disord. 2011, 26:2140-2141.
150. Sharma N., Hewett J., Ozelius L.J., Ramesh V., McLean P.J., Breakefield X.O., Hyman B.T. A close association of torsinA and alpha-synuclein in Lewy bodies: a fluorescence resonance energy transfer study. Am. J. Path. 2001, 159:339-344.
151. Shashidharan P., Good P.F., Hsu A., Perl D.P., Brin M.F., Olanow C.W. TorsinA accumulation in Lewy bodies in sporadic Parkinson's disease. Brain Res. 2000, 877:379-381.
152. Shashidharan P., Paris N., Sandu D., Karthikeyan L., McNaught K.S., Walker R.H., Olanow C.W. Overexpression of torsinA in PC12 cells protects against toxicity. J. Neurochem. 2004, 88:1019-1025.
153. Shen Y., Lee H.Y., Rawson J., Ojha S., Babbitt P., Fu Y.H., Ptácek L.J. Mutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stability. Hum. Mol. Genet. 2011, 20:2322-2332.
154. Spacey S.D., Adams P.J., Lam P.C., Materek L.A., Stoessl A.J., Snutch T.P., Hsiung G.Y. Genetic heterogeneity in paroxysmal nonkinesigenic dyskinesia. Neurology 2006, 66:1588-1590.
155. Spacey S.D., Valente E.M., Wali G.M., Warner T.T., Jarman P.R., Schapira A.H., Dixon P.H., Davis M.B., Bhatia K.P., Wood N.W. Genetic and clinical heterogeneity in paroxysmal kinesigenic dyskinesia: evidence for a third EKD gene. Mov. Disord. 2002, 17:717-725.
156. Spina S., Murrell J.R., Yoshida H., Ghetti B., Bermingham N., Sweeney B., Dlouhy S.R., Crowther R.A., Goedert M., Keohane C. The novel Tau mutation G335S: clinical, neuropathological and molecular characterization. Acta Neuropathol. 2007, 113:461-470.
157. Steinberger D., Blau N., Goriuonov D., Bitsch J., Zuker M., Hummel S., Müller U. Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia. Neurogenetics 2004, 5:187-190.
158. Swerdlow R.H., Wooten G.F. A novel deafness/dystonia peptide gene mutation that causes dystonia in female carriers of Mohr-Tranebjaerg syndrome. Ann. Neurol. 2001, 50:537-540.
159. Swoboda K.J. Disorders of amine biosynthesis. Future Neurol. 2006, 1:605-614.
160. Szepetowski P., Rochette J., Berquin P., Piussan C., Lathrop G.M., Monaco A.P. Familial infantile convulsions and paroxysmal choreoathetosis: a new neurological syndrome linked to the pericentromeric region of human chromosome 16. Am. J. Hum. Genet. 1997, 61:889-898.
161. Tarsy D., Sweadner K.J., Song P.C. Case records of the Massachusetts General Hospital. Case 17-2010-a 29-year-old woman with flexion of the left hand and foot and difficulty speaking. New Engl. J. Med. 2010, 362:2213-2219.
162. Thiffault I., Rioux M.F., Tetreault M., Jarry J., Loiselle L., Poirier J., Gros-Louis F., Mathieu J., Vanasse M., Rouleau G.A., et al. A new autosomal recessive spastic ataxia associated with frequent white matter changes maps to 2q33-34. Brain 2006, 129:2332-2340.
163. Thöny B., Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum. Mutat. 2006, 27:870-878.
164. Tolosa E., Compta Y. Dystonia in Parkinson's disease. J. Neurol. 2006, 253(Suppl. 7):VII7-VII13.
165. Tomita H., Nagamitsu S., Wakui K., Fukushima Y., Yamada K., Sadamatsu M., Masui A., Konishi T., Matsuishi T., Aihara M., et al. Paroxysmal kinesigenic choreoathetosis locus maps to chromosome 16p11.2-q12.1. Am. J. Hum. Genet. 1999, 65:1688-1697.
166. Tońska K., Kodron A., Bartnik E. Genotype-phenotype correlations in Leber hereditary optic neuropathy. Biochim. Biophys. Acta 2010, 1797:1119-1123.
167. Torres G.E., Sweeney A.L., Beaulieu J.M., Shashidharan P., Caron M.G. Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated DeltaE-torsinA mutant. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:15650-15655.
168. Uitti R.J., Maraganore D.M. Adult onset familial cervical dystonia: report of a family including monozygotic twins. Mov. Disord. 1993, 8:489-494.
169. Vale R.D. AAA proteins. Lords of the ring. J. Cell Biol. 2000, 150:F13-19.
170. Valente E.M., Bentivoglio A.R., Cassetta E., Dixon P.H., Davis M.B., Ferraris A., Ialongo T., Frontali M., Wood N.W., Albanese A. DYT13, a novel primary torsion dystonia locus, maps to chromosome 1p36.13-36.32 in an Italian family with cranial-cervical or upper limb onset. Ann. Neurol. 2001, 49:362-366.
171. Valente E.M., Spacey S.D., Wali G.M., Bhatia K.P., Dixon P.H., Wood N.W., Davis M.B. A second paroxysmal kinesigenic choreoathetosis locus (EKD2) mapping on 16q13-q22.1 indicates a family of genes which give rise to paroxysmal disorders on human chromosome 16. Brain 2000, 123:2040-2045.
172. Valente E.M., Warner T.T., Jarman P.R., Mathen D., Fletcher N.A., Marsden C.D., Bhatia K.P., Wood N.W. The role of DYT1 in primary torsion dystonia in Europe. Brain 1998, 121:2335-2339.
173. van Gaalen J., Giunti P., van de Warrenburg B.P. Movement disorders in spinocerebellar ataxias. Mov. Disord. 2011, 26:792-800.
174. Van Gerpen J.A., LeDoux M.S., Wszolek Z.K. Adult-onset leg dystonia due to a missense mutation in THAP1. Mov. Disord. 2010, 25:1306-1307.
175. Vander Heyden A.B., Naismith T.V., Snapp E.L., Hanson P.I. Static retention of the lumenal monotopic membrane protein torsinA in the endoplasmic reticulum. EMBO J. 2011, 30:3217-3231.
176. Vasudevan A., Breakefield X.O., Bhide P.G. Developmental patterns of torsinA and torsinB expression. Brain Res. 2006, 1073-1074:139-145.
177. Verbeek M.M., Steenbergen-Spanjers G.C., Willemsen M.A., Hol F.A., Smeitink J., Seeger J., Grattan-Smith P., Ryan M.M., Hoffmann G.F., Donati M.A., et al. Mutations in the cyclic adenosine monophosphate response element of the tyrosine hydroxylase gene. Ann. Neurol. 2007, 62:422-426.
178. Verrotti A., D'Egidio C., Agostinelli S., Gobbi G. Glut1 deficiency: when to suspect and how to diagnose?. Eur. J. Paediatr. Neurol. 2012, 16:3-9.
179. Waite A., Tinsley C.L., Locke M., Blake D.J. The neurobiology of the dystrophin-associated glycoprotein complex. Ann. Med. 2009, 41:344-359.
180. Walker R.H., Good P.F., Shashidharan P. TorsinA immunoreactivity in inclusion bodies in trinucleotide repeat diseases. Mov. Disord. 2003, 18:1041-1044.
181. Waln O., LeDoux M.S. Blepharospasm plus cervical dystonia with predominant anterocollis: a distinctive subphenotype of segmental craniocervical dystonia?. Tremor Other Hyperkinet. Mov. (N.Y.) 2011, 1. pii: 33.
182. Wang J.L., Cao L., Li X.H., Hu Z.M., Li J.D., Zhang J.G., Liang Y., San A., Li N., Chen S.Q., et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain 2011, 134:3493-3501.
183. Weber Y.G., Kamm C., Suls A., Kempfle J., Kotschet K., Schule R., Wuttke T.V., Maljevic S., Liebrich J., Gasser T., et al. Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect. Neurology 2011, 77:959-964.
184. Weber Y.G., Lerche H. Genetics of paroxysmal dyskinesias. Curr. Neurol. Neurosci. Rep. 2009, 9:206-211.
185. Weber Y.G., Storch A., Wuttke T.V., Brockmann K., Kempfle J., Maljevic S., Margari L., Kamm C., Schneider S.A., Huber S.M., et al. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J. Clin. Invest. 2008, 118:2157-2168.
186. Weiss E.M., Hershey T., Karimi M., Racette B., Tabbal S.D., Mink J.W., Paniello R.C., Perlmutter J.S. Relative risk of spread of symptoms among the focal onset primary dystonias. Mov. Disord. 2006, 21:1175-1181.
187. Weraarpachai W., Antonicka H., Sasarman F., Seeger J., Schrank B., Kolesar J.E., Lochmuller H., Chevrette M., Kaufman B.A., Horvath R., et al. Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh syndrome. Nat. Genet. 2009, 41:833-837.
188. Werner E.R., Blau N., Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem. J. 2011, 438:397-414.
189. Wider C., Melquist S., Hauf M., Solida A., Cobb S.A., Kachergus J.M., Gass J., Coon K.D., Baker M., Cannon A., et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology 2008, 70:1377-1383.
190. Wilcox R.A., Winkler S., Lohmann K., Klein C. Whispering dysphonia in an Australian family (DYT4): a clinical and genetic reappraisal. Mov. Disord. 2011, 26:2404-2408.
191. Willemsen M.A., Verbeek M.M., Kamsteeg E.J., de Rijk-van Andel J.F., Aeby A., Blau N., Burlina A., Donati M.A., Geurtz B., Grattan-Smith P.J., et al. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 2010, 133:1810-1822.
192. Wu Y.R., Lee-Chen G.J., Lang A.E., Chen C.M., Lin H.Y., Chen S.T. Dystonia as a presenting sign of spinocerebellar ataxia type 1. Mov. Disord. 2004, 19:586-587.
193. Xiao J., Bastian R.W., Perlmutter J.S., Racette B.A., Tabbal S.D., Karimi M., Paniello R.C., Blitzer A., Batish S.D., Wszolek Z.K., et al. High-throughput mutational analysis of TOR1A in primary dystonia. BMC Med. Genet. 2009, 10:24.
194. Xiao J., Gong S., Zhao Y., LeDoux M.S. Developmental expression of rat torsinA transcript and protein. Brain Res. Dev. Brain Res. 2004, 152:47-60.
195. Xiao J., LeDoux M.S. Cloning, developmental regulation and neural localization of rat epsilon-sarcoglycan. Mol. Brain Res. 2003, 119:132-143.
196. Xiao J., Uitti R.J., Zhao Y., Vemula S.R., Perlmutter J.S., Wszolek Z.K., Maraganore D.M., Auburger G., Leube B., Lehnhoff K., et al. Mutations in CIZ1 cause adult-onset primary cervical dystonia. Ann. Neurol. 2012, 71:458-469.
197. Xiao J., Zhao Y., Bastian R.W., Perlmutter J.S., Racette B.A., Tabbal S.D., Karimi M., Paniello R.C., Wszolek Z.K., Uitti R.J., et al. Novel THAP1 sequence variants in primary dystonia. Neurology 2010, 74:229-238.
198. Xiao J., Zhao Y., Bastian R.W., Perlmutter J.S., Racette B.A., Tabbal S.D., Karimi M., Paniello R.C., Wszolek Z.K., Uitti R.J., et al. The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia. Mov. Disord. 2011, 26:549-552.
199. Zhao Y., Xiao J., Ueda M., Wang Y., Hines M., Nowak T.S., LeDoux M.S. Glial elements contribute to stress-induced torsinA expression in the CNS and peripheral nervous system. Neuroscience 2008, 155:439-453.
200. Zimprich A., Grabowski M., Asmus F., Naumann M., Berg D., Bertram M., Scheidtmann K., Kern P., Winkelmann J., Muller-Myhsok B., et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat. Genet. 2001, 29:66-69.
201. Zirn B., Grundmann K., Huppke P., Puthenparampil J., Wolburg H., Riess O., Müller U. Novel TOR1A mutation p.Arg288Gln in early-onset dystonia (DYT1). J. Neurol. Neurosurg. Psychiatry 2008, 79:1327-1330.
202. Zirn B., Steinberger D., Troidl C., Brockmann K., von der Hagen M., Feiner C., Henke L., Müller U. Frequency of GCH1 deletions in dopa-responsive dystonia. J. Neurol. Neurosurg. Psychiatry 2008, 79:183-186.